LYB vs NRXS · P/E 21, rev $16.37B vs rev $3.6M
LyondellBasell Industries NV (LYB) versus Neuraxis, Inc. (NRXS) — a side-by-side from cached financials, not a winner call.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
Neuraxis, Inc. (NRXS) is a biotechnology company listed on AMEX.
Latest reported LYB revenue for 2026-06-30 was $16.37B. Net income was $684.0M. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
Latest reported NRXS revenue for 2025-12-31 was $3.6M. Net income was -$7.8M. Revenue was up 32.9% from 2024-12-31 to 2025-12-31. NRXS currently screens at market cap $83.1M.
LYB currently screens at market cap $19.93B and trailing P/E 21.5. NRXS currently screens at market cap $83.1M.
Not investment advice. Open the LYB and NRXS stock pages for the full models.
Not investment advice.